In a report released yesterday, Elizabeth Anderson CFA from Evercore ISI maintained a Buy rating on Privia Health Group (PRVA – Research Report), with a price target of $22.00. The company’s ...
Privia Health Group Inc (NASDAQ:PRVA) exceeded the high end of all guidance metrics for 2024, showcasing strong performance across all markets. Implemented providers increased by 11.2% year over ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Privia Health Group, Inc.: Privia Health Reports Fourth Quarter and Full-Year 2024 Financial Results
Feb. 27, 2025 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) today announced financial and operating results for the fourth quarter and full year ended December 31, 2024. Each of the ...
ARLINGTON, Va. (AP) — ARLINGTON, Va. (AP) — Privia Health Group Inc. (PRVA) on Thursday reported fourth-quarter profit of $4.4 million. The Arlington, Virginia-based company said it had net ...
2025 Financial and Business Outlook g h i Privia Health’s key actions and areas of focus in 2025 include: Increasing density and scale in existing states through organic provider growth ...
Privia Health Group Inc (PRVA) reported robust financial results for the fourth quarter of 2024, surpassing Wall Street expectations. The company posted an earnings per share (EPS) of $0.21 ...
Feb. 27, 2025 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) today announced financial and operating results for the fourth quarter and full year ended December 31, 2024. Each of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback